PBE Top Holdings & Constituents
PBE, offered by Invesco, holds 33 reported positions across $286.2M in assets. Its largest holdings are Invesco Private Prime Fund (10.92%), United Therapeutics Corp. (UTHR) (6.28%), and Illumina, Inc. (ILMN) (5.37%). The 5 biggest positions account for 32.53% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
— Invesco Private Prime Fund | 10.92% | $27.00M |
UTHR United Therapeutics Corp. | 6.28% | $15.55M |
ILMN Illumina, Inc. | 5.37% | $13.29M |
BIIB Biogen Inc. | 5.05% | $12.50M |
INCY Incyte Corp. | 4.91% | $12.15M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Apr 30, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.